DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $244.16 million. The enterprise value is $194.33 million.

Market Cap	244.16M
Enterprise Value	194.33M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

DMAC has 42.76 million shares outstanding. The number of shares has increased by 32.12% in one year.

Current Share Class	42.76M
Shares Outstanding	42.76M
Shares Change (YoY)	+32.12%
Shares Change (QoQ)	+12.30%
Owned by Insiders (%)	38.56%
Owned by Institutions (%)	13.34%
Float	24.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.09
P/TBV Ratio	5.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.81, with a Debt / Equity ratio of 0.01.

Current Ratio	11.81
Quick Ratio	11.75
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.90% and return on invested capital (ROIC) is -28.87%.

Return on Equity (ROE)	-41.90%
Return on Assets (ROA)	-27.23%
Return on Capital (ROIC)	-28.87%
Revenue Per Employee	n/a
Profits Per Employee	-$1.14M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $43,000 in taxes.

Income Tax	43,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +99.65% in the last 52 weeks. The beta is 1.46, so DMAC's price volatility has been higher than the market average.

Beta (5Y)	1.46
52-Week Price Change	+99.65%
50-Day Moving Average	5.04
200-Day Moving Average	3.83
Relative Strength Index (RSI)	56.89
Average Volume (20 Days)	100,748

Short Selling Information

The latest short interest is 222,800, so 0.52% of the outstanding shares have been sold short.

Short Interest	222,800
Short Previous Month	194,566
Short % of Shares Out	0.52%
Short % of Float	0.92%
Short Ratio (days to cover)	3.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-24.11M
Pretax Income	-19.85M
Net Income	-21.71M
EBITDA	-24.07M
EBIT	-24.11M
Earnings Per Share (EPS)	-$0.55

Full Income Statement

Balance Sheet

The company has $50.20 million in cash and $365,000 in debt, giving a net cash position of $49.83 million or $1.17 per share.

Cash & Cash Equivalents	50.20M
Total Debt	365,000
Net Cash	49.83M
Net Cash Per Share	$1.17
Equity (Book Value)	47.96M
Book Value Per Share	1.12
Working Capital	46.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.45 million and capital expenditures -$21,000, giving a free cash flow of -$19.48 million.

Operating Cash Flow	-19.45M
Capital Expenditures	-21,000
Free Cash Flow	-19.48M
FCF Per Share	-$0.46

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.12%
Shareholder Yield	-32.12%
Earnings Yield	-8.89%
FCF Yield	-7.98%

Analyst Forecast

The average price target for DMAC is $7.00, which is 22.59% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	22.59%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-43.00%

Stock Forecasts

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1